BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32886897)

  • 21. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography).
    Groheux D
    PET Clin; 2023 Oct; 18(4):503-515. PubMed ID: 37268506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
    Groheux D
    Semin Nucl Med; 2022 Sep; 52(5):508-519. PubMed ID: 35636977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
    Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
    Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C; Liang Z; Liu W; Zeng X; Mo Y
    BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
    Morkel M; Ellmann A; Warwick J; Simonds H
    Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Srour MK; Lee M; Walcott-Sapp S; Luu M; Chung A; Giuliano AE; Amersi F
    Ann Surg Oncol; 2019 Oct; 26(10):3289-3294. PubMed ID: 31342365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
    Cermik TF; Mavi A; Basu S; Alavi A
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):475-83. PubMed ID: 17957366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of FDG PET/CT in the clinical management of breast cancer.
    Groheux D; Espié M; Giacchetti S; Hindié E
    Radiology; 2013 Feb; 266(2):388-405. PubMed ID: 23220901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study.
    Richters A; van Ginkel N; Meijer RP; Wondergem M; Schoots I; Vis AN; Kiemeney LALM; van Rhijn BWG; Witjes JA; Aben KKH; Mertens LS
    BJU Int; 2023 Oct; 132(4):420-427. PubMed ID: 37246479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer.
    Aliyev A; Yilmaz Aksoy S; Özhan M; Ekmekçioğlu Ö; Vatankulu B; Kocael PÇ; Sağer MS; Erkan ME; Sönmezoğlu K; Halaç M
    Turk J Med Sci; 2016 Feb; 46(2):349-60. PubMed ID: 27511496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact.
    Vogsen M; Jensen JD; Christensen IY; Gerke O; Jylling AMB; Larsen LB; Braad PE; Søe KL; Bille C; Ewertz M; Hildebrandt MG
    Breast Cancer Res Treat; 2021 Jan; 185(1):145-153. PubMed ID: 32920740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
    Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
    Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
    Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
    Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is PET/CT Necessary in the Management of Early Breast Cancer?
    Nursal GN; Nursal TZ; Aytac HO; Hasbay B; Torun N; Reyhan M; Yapar AF
    Clin Nucl Med; 2016 May; 41(5):362-5. PubMed ID: 26914560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
    Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer.
    Özdemir A; Güven M; Binici S; Uygur S; Toktaş O
    Clin Transl Oncol; 2024 May; 26(5):1139-1146. PubMed ID: 37848693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
    Soubra A; Hayward D; Dahm P; Goldfarb R; Froehlich J; Jha G; Konety BR
    World J Urol; 2016 Sep; 34(9):1229-37. PubMed ID: 26847182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
    Garami Z; Hascsi Z; Varga J; Dinya T; Tanyi M; Garai I; Damjanovich L; Galuska L
    Eur J Surg Oncol; 2012 Jan; 38(1):31-7. PubMed ID: 21937190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.
    Caresia Aroztegui AP; García Vicente AM; Alvarez Ruiz S; Delgado Bolton RC; Orcajo Rincon J; Garcia Garzon JR; de Arcocha Torres M; Garcia-Velloso MJ;
    Tumour Biol; 2017 Oct; 39(10):1010428317728285. PubMed ID: 29025377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.